Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Comparison of CJ-12420 Formulations in Healthy Volunteers
NCT02995239Phase 1Completed
- Sponsor
- HK inno.N Corporation
- Start
- Apr 2015
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tegoprazan in erosive esophagitis (EE) (2 arms), sponsored by HK inno.N Corporation. Primary endpoint: Area Under the Curve to the Last Measurable Concentration up to 48 hours. Started Apr 2015; status: completed.
02
Drugs
tegoprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT02995239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02995239.